National prices for serputinib/serpatinib
Selpercatinib/Selpercatinib is a targeted drug targeting RET gene mutations, such as non-small cell lung cancer, thyroid cancer, medullary thyroid cancer, etc. As a drug with central nervous system (CNS) activity, seputinib stands out for its highly selective and potent ability to target RET kinase. It is currently available in many countries and regions. Prices in different countries vary depending on factors such as region, medical insurance policies, and drug production costs.
The original drug Seputinib is produced by Eli Lilly and Company and sold overseasand is relatively expensiveThe price of each box of the European and American versions is between20,000 to more than 100,000 yuan (the price may fluctuate due to the exchange rate). However, specific prices vary depending on factors such as treatment dosage, length of treatment, and where you purchase it. In addition, the U.S. government also subsidizes the drug costs of some patients through medical insurance policies to reduce their financial burden.

In China, the price of seputinib is also relatively high,SpecificationsThe price of 80mg*56 capsules per box may be more than 10,000 yuan.However, the specific prices vary depending on factors such as drug production costs, market supply and demand, and medical insurance policies. Currently, this drug is not included in China’s medical insurance list, so patients need to purchase it at their own expense. However, with the continuous development of drugs and intensified market competition, the price of seputinib may gradually decrease.
Up to now, it is also available overseasSeputinibGeneric drugs are on the market, and their drug ingredients are basically the same as those of original drugs sold domestically and abroad. For example, the specifications produced by Laos Pharmaceutical FactoryThe price of each box of 40mg*120 tablets is more than 4,000 yuan (the price may fluctuate due to the exchange rate). For more overseas drug information and specific prices, please consult Yaode Medical Consultant.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)